NEW YORK--(BUSINESS WIRE)--
(NASDAQ: MDSO), the leading global provider of cloud-based solutions for
clinical research in life sciences, today announced that Rouven
Bergmann, chief financial officer, will present at the J.P. Morgan 35th
Annual Healthcare Conference on Thursday, January 12, 2017, at 8:00 a.m.
PT (11:00 a.m. ET) in San Francisco.
A live audio webcast will be available on the "Investor" section of
Medidata's website at http://investor.mdsol.com.
Please visit the website at least 15 minutes prior to the event to
register, download and install any necessary audio or video software to
access the presentation. For those unable to participate in the live
webcast, a replay will be archived on the "Investor" section of
Medidata's website at http://investor.mdsol.com
for a limited period of time following the conference.
is reinventing global drug development by creating the industry's
leading cloud-based solutions for clinical research. Through our
advanced applications and intelligent data analytics, Medidata helps
advance the scientific goals of life sciences customers worldwide,
including nearly 800 global pharmaceutical companies, innovative
biotech, diagnostic and device firms, leading academic medical centers,
and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 17 of the world's top 25 global
pharmaceutical companies, from study design and planning through
execution, management and reporting.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170103005184/en/
D'Amico, +1 732-767-4331
Nicole Pariser, +1 212-659-1069
News Provided by Acquire Media